A unique platform able to quantify systemic complement protein levels thereby supporting patient stratification and disease monitoring

A unique platform able to quantify systemic complement protein levels thereby supporting patient stratification and disease monitoring

The CPM platform provides, for the first time, the opportunity to accurately measure >30 complement proteins from a single systemically drawn blood sample. This includes C3 and its breakdown products, Factor I, Factor H, FHL-1 as well as the FHR family of proteins. 

The CPM platform will facilitate the stratification of patients with AMD and other conditions for enrolment into future clinical trials as well as supporting the subsequent commercialisation of our assets. 

Presently the CPM platform has been validated in normal human samples and two distinct disease cohorts (Cipriani and Unwin et al., Am J Hum Genet, 2021)

4th Floor, Central Working White City
Translation and Innovation Hub
84 Wood Lane
London, W12 0BZ
United Kingdom


Created by HTP Digital